These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2445506)

  • 1. Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies.
    Scott MG; Cuca GC; Petersen JR; Lyle LR; Burleigh BD; Daughaday WH
    Clin Chem; 1987 Nov; 33(11):2019-23. PubMed ID: 2445506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor.
    Morrell DJ; Dadi H; More J; Taylor AM; Dabestani A; Buchanan CR; Holder AT; Preece MA
    J Mol Endocrinol; 1989 May; 2(3):201-6. PubMed ID: 2751828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for the measurement of insulin-like growth factor I in patients with pituitary disease in comparison with commercially available somatomedin-C radioimmunoassays.
    Pfeifle B; Maier V; Ditschuneit H
    J Clin Chem Clin Biochem; 1986 Jun; 24(6):393-8. PubMed ID: 3746204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of radioimmunoassay for measurement of insulin-like growth factor-I (IGF-I) by using anti-IGF-I monoclonal antibody.
    Tominaga M; Tominaga K; Kinoshita Y; Terano Y; Yamamoto K
    Cell Mol Biol (Noisy-le-grand); 1995 Jun; 41(4):505-14. PubMed ID: 7549787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay.
    Crosby SR; Anderton CD; Westwood M; Holly JM; Cwyfan Hughes SC; Gibson M; Morrison CA; Young RJ; White A
    J Endocrinol; 1993 Apr; 137(1):141-50. PubMed ID: 8492071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunoradiometric assay of thyroglobulin in serum with use of monoclonal antibodies selected for lack of cross-reactivity with autoantibodies.
    Piechaczyk M; Baldet L; Pau B; Bastide JM
    Clin Chem; 1989 Mar; 35(3):422-4. PubMed ID: 2465845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoradiometric assay measurements of insulin-like growth factor-I (IGF-I): comparison with radioimmunoassays using native or des (1-3) IGF-I as radioligands.
    Homayoun P; Daher R; Van Lente F; Faiman C; Gupta MK
    J Clin Lab Anal; 1996; 10(6):446-50. PubMed ID: 8951618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I.
    Cascieri MA; Bayne ML; Ber E; Green BG; Men GW; Chicchi GG
    Endocrinology; 1990 Jun; 126(6):2773-7. PubMed ID: 1693561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of insulin-like growth factor I: clinical applications and significance.
    Teale JD; Marks V
    Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal and polyclonal antibodies compared for radioimmunoassay of somatomedin-C in patients with acromegaly or hypopituitarism.
    Burrin JM; Paterson JL; Sharp PS; Yeo TH
    Clin Chem; 1987 Sep; 33(9):1593-6. PubMed ID: 3621559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibodies recognising different epitopes present on insulin-like growth factor 1.
    Harvey D; Jones WT; Jones SD; Ryan GB
    Hybridoma; 1993 Dec; 12(6):737-44. PubMed ID: 7507085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies directed to human insulin-like growth factor I (IGF I). Use for radioimmunoassay and immunopurification of IGF.
    Laubli UK; Baier W; Binz H; Celio MR; Humbel RE
    FEBS Lett; 1982 Nov; 149(1):109-12. PubMed ID: 6759172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
    Lassarre C; Binoux M
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables.
    Busby WH; Snyder DK; Clemmons DR
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1225-30. PubMed ID: 2461386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.
    Blum WF; Ranke MB; Bierich JR
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):374-80. PubMed ID: 2455951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.
    Enjoh T; Hizuka N; Perdue JF; Takano K; Fujiwara H; Higashihashi N; Marumoto Y; Fukuda I; Sakano K
    J Clin Endocrinol Metab; 1993 Aug; 77(2):510-7. PubMed ID: 7688378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of insulin-like growth factor II are not changed by short-term fasting and refeeding.
    Davenport ML; Svoboda ME; Koerber KL; Van Wyk JJ; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1231-6. PubMed ID: 3192679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a heterologous radioimmunoassay for insulin-like growth factor-I in bovine serum.
    Holland MD; Hossner KL; Niswender GD; Elsasser TH; Odde KG
    J Endocrinol; 1988 Nov; 119(2):281-5. PubMed ID: 3199060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
    Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.